Cargando…

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

BACKGROUND: Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF. However, the safety and effectiveness of pirfenidone in asbestosis patients remain unclear. In this study, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miedema, Jelle R., Moor, Catharina C., Veltkamp, Marcel, Baart, Sara, Lie, Natascha S. L., Grutters, Jan C., Wijsenbeek, Marlies S., Mostard, Rémy L. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148498/ https://www.ncbi.nlm.nih.gov/pubmed/35643466 http://dx.doi.org/10.1186/s12931-022-02061-2

Ejemplares similares

The use of online visual analogue scales in idiopathic pulmonary fibrosis
por: Moor, Catharina C., et al.
Publicado: (2022)

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study
por: Moor, C. C., et al.
Publicado: (2020)

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population
por: Kahlmann, Vivienne, et al.
Publicado: (2021)

Early Experience of Pirfenidone in Daily Clinical Practice in Belgium and The Netherlands: a Retrospective Cohort Analysis
por: Wijsenbeek, Marlies S., et al.
Publicado: (2015)

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

Silicosis and Asbestosis
Publicado: (1939)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
por: Lancaster, Lisa H., et al.
Publicado: (2017)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Managing Fatigue in Patients With Interstitial Lung Disease
por: Kahlmann, Vivienne, et al.
Publicado: (2020)

Role of the internet of medical things in care for patients with interstitial lung disease
por: Nakshbandi, Gizal, et al.
Publicado: (2023)

Pirfenidone: is it tolerable?
por: Lara, Abigail, et al.
Publicado: (2016)

Smoking-associated fibrosis and pulmonary asbestosis
por: Bledsoe, Jacob R, et al.
Publicado: (2014)

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis
por: Moor, Catharina C., et al.
Publicado: (2019)

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis
por: Moor, Catharina C., et al.
Publicado: (2017)

Radiologic Diagnosis of Asbestosis in Korea
por: Cha, Yoon Ki, et al.
Publicado: (2016)

Imaging and imagination in the diagnostics of asbestosis
por: Candura, Stefano M., et al.
Publicado: (2020)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Artificial intelligence-based diagnosis of asbestosis: analysis of a database with applicants for asbestosis state aid
por: Groot Lipman, Kevin B. W., et al.
Publicado: (2022)

Comprehensive Care for Patients with Sarcoidosis
por: Moor, Catharina C., et al.
Publicado: (2020)

Exhaled breath analysis in interstitial lung disease
por: van der Sar, Iris G., et al.
Publicado: (2023)

Clinical, Radiological, and Pathological Investigation of Asbestosis
por: Kishimoto, Takumi, et al.
Publicado: (2011)

Feasibility of online home spirometry in systemic sclerosis–associated interstitial lung disease: a pilot study
por: Moor, Catharina C, et al.
Publicado: (2020)

Antemortem diagnosis of asbestosis by screening chest radiograph correlated with postmortem histologic features of asbestosis: a study of 273 cases
por: Mizell, Kelly N, et al.
Publicado: (2009)

Carcinoma and Asbestosis of the Lung: Report of a Case
por: Owen, T. K.
Publicado: (1951)

Squamous Cell Carcinoma Occurring in Asbestosis of the Lung
por: Cureton, R. J. R.
Publicado: (1948)

Spontaneous Tension Hemothorax in a Patient with Asbestosis
por: Suzuki, Toshinao, et al.
Publicado: (2022)

Manganese and Extracellular Superoxide Dismutase Polymorphisms and Risk for Asbestosis
por: Franko, Alenka, et al.
Publicado: (2009)

Asbestosis: Past voices from the Mumbai factory floor
por: Jadhav, Abhijeet V., et al.
Publicado: (2012)

Pleural plaques in smoking-associated fibrosis and pulmonary asbestosis
por: Sangani, Rahul G, et al.
Publicado: (2015)

Asbestosis is prevalent in a variety of construction industry trades
por: Walters, G. I., et al.
Publicado: (2018)

Asbestosis Mimicking Metastatic Lung Cancer: Case Report
por: An, Jin, et al.
Publicado: (2021)

Expression of microRNAs in leukocytes and serum of asbestosis patients
por: Kauschke, Vivien, et al.
Publicado: (2023)

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era
por: Nakshbandi, Gizal, et al.
Publicado: (2021)

Pulmonary Endpoints (Lung Carcinomas and Asbestosis) Following Inhalation Exposure to Asbestos
por: Mossman, Brooke T., et al.
Publicado: (2011)

Asbestosis in an asbestos composite mill at Mumbai: A prevalence study
por: Murlidhar, V, et al.
Publicado: (2005)

Asbestos, asbestosis, and lung cancer: observations in Quebec chrysotile workers.
por: Case, B W, et al.
Publicado: (1997)

Inducible Nitric Oxide Synthase Genetic Polymorphism and Risk of Asbestosis
por: Franko, Alenka, et al.
Publicado: (2011)

The Influence of Gene-Gene and Gene-Environment Interactions on the Risk of Asbestosis
por: Franko, A., et al.
Publicado: (2013)

Distribution of Asbestos Enterprises and Asbestosis Cases — China, 1997−2019
por: Chen, Mingfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ilu8suijknmno5tf2if3h8gc37